abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
94015: HIV-1 Genotype and Coreceptor Tropism, Ultradeep Sequencing Print View
HIV-1 Genotype      
CXCR4(X4)      
Tropism Assessment      
MVC Activity Anticipated      

PRIMARY
1 Plasma EDTA 4 (1.2) mL   Frozen - 30 Day(s)/Refrigerated - 5 Day(s)/Room Temperature - 24 Hour(s)  
ALTERNATE
  Plasma PPT Tube 4 (1.2) mL   Frozen - 30 Day(s)/Refrigerated - 5 Day(s)/Room Temperature - 24 Hour(s)  

Select antiretroviral drug regimen for treating HIV-1 patients by assessing reverse transcriptase and protease inhibitor resistance, together with CCR5 antagonist eligibility.

Collect blood in sterile tubes containing EDTA
anticoagulant (lavender-top) or PPT (white-top) tube.
Separate plasma from the cells by centrifugation within 24
hours after collection, transfer the plasma to a separate
plastic screw-cap vial, and ship frozen.
Setup Schedule
Monday, Thursday

Reported (Analytical Time)
4 days

CPT Codes
87901,87900,87906

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Methodology: Reverse Transcriptase Polymerase Chain Reaction, Ultra-deep Sequencing Transport Temperature: Frozen Gross hemolysis; lipemia; received room temperature; heparinized plasma; serum; non-centrifuged PPT; frozen PPT (in situ)






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database